stockrowMaravai LifeSciences Holdings, Inc.
MRVI Healthcare Biotechnology
Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024.
- Revenue
- +10.1%
- EPS
- +50.0%
- Free cash flow
- +123.9%
- Total debt
- −45.4%
Quarter to September 2026, against a year earlier
Follow MRVI
Alert me
Maravai LifeSciences Holdings, Inc. (MRVI) Book value per share
Maravai LifeSciences Holdings, Inc.'s book value per share at the end of fiscal 2025 was 2.6×, down 38.3% from 4.2× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 2.3×. Over the past ten years it has ranged from 0.6× (fiscal 2019) to 14.9× (fiscal 2020); the current reading is higher than 38% of that period. Maravai LifeSciences Holdings, Inc. ranks 258th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 2.6× | (38.32%) |
| FY2024 | 4.2× | (30.10%) |
| FY2023 | 6.0× | (12.99%) |
| FY2022 | 6.9× | 44.85% |
| FY2021 | 4.8× | (68.22%) |
| FY2020 | 14.9× | 2,524.63% |
| FY2019 | 0.6× | (2.28%) |
| FY2018 | 0.6× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 2.3× | (5.02%) |
| Jun 2026 | 2.4× | (4.68%) |
| Mar 2026 | 2.5× | (2.37%) |
| Dec 2025 | 2.6× | (13.50%) |
| 25 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | 18.4× |
| SRPT Sarepta Therapeutics, Inc. compare | 14.4× |
| MAZE Maze Therapeutics, Inc. compare | 7.7× |
| VIR Vir Biotechnology, Inc. compare | 5.3× |
| TRAX First Tracks Biotherapeutics, Inc. compare | 4.2× |
| MRVI Maravai LifeSciences Holdings, Inc. | 2.3× |
| TRVI Trevi Therapeutics, Inc. compare | 2.1× |
| REPL Replimune Group, Inc. compare | 1.9× |
| MESO Mesoblast Limited compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))